Peptide-based cancer vaccines

被引：68
|
作者：
Melief, CJM [1 ]
Offringa, R [1 ]
Toes, REM [1 ]
Kast, WM [1 ]
机构：
[1] LOYOLA UNIV, CARDINAL BERNADIN CANC CTR, CANC IMMUNOL PROGRAM, MAYWOOD, IL 60153 USA
来源：
CURRENT OPINION IN IMMUNOLOGY | 1996年 / 8卷 / 05期
关键词：
D O I：
10.1016/S0952-7915(96)80081-1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The application of molecularly defined vaccines composed of a limited number of tumor-specific T cell epitopes has resulted in protective antitumor T cell immunity in several mouse tumor models. The first encouraging results with such vaccines have been obtained in human beings. The development of the next generation of rationally designed vaccines that are both effective and safe for application in a clinical setting requires comparison of different modes of delivery of tumor-associated T cell epitopes in multiple epitope constructs.
引用
收藏
页码：651 / 657
页数：7
相关论文
共 50 条
  • [31] Design and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines
    Song, Kefan
    Pun, Suzie H.
    BME FRONTIERS, 2024, 5
  • [32] Cell-free tumor antigen peptide-based cancer vaccines
    Schmidt, W
    Buschle, M
    Zauner, W
    Kirlappos, H
    Mechtler, K
    Trska, B
    Birnstiel, ML
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) : 3262 - 3267
  • [33] Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines
    Grau, Morgan
    Walker, Paul R.
    Derouazi, Madiha
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2018, 75 (16) : 2887 - 2896
  • [34] Synthetic peptide-based vaccines against influenza
    Ben-Yedidia, T
    Arnon, R
    LETTERS IN PEPTIDE SCIENCE, 1998, 5 (5-6): : 341 - 344
  • [35] Synthetic Peptide-Based Vaccines Against Influenza
    Tamar Ben-Yedidia
    Ruth Arnon
    Letters in Peptide Science, 1998, 5 : 341 - 344
  • [36] Rational design of peptide-based tumor vaccines
    Meng, WS
    Butterfield, LH
    PHARMACEUTICAL RESEARCH, 2002, 19 (07) : 926 - 932
  • [37] Trial Watch: Peptide-based anticancer vaccines
    Pol, Jonathan
    Bloy, Norma
    Buque, Aitziber
    Eggermont, Alexander
    Cremer, Isabelle
    Sautes-Fridman, Catherine
    Galon, Jerome
    Tartour, Eric
    Zitvogel, Laurence
    Kroemer, Guido
    Galluzzi, Lorenzo
    ONCOIMMUNOLOGY, 2015, 4 (04):
  • [38] Pitfalls of reductionism in the design of peptide-based vaccines
    Van Regenmortel, MHV
    VACCINE, 2001, 19 (17-19) : 2369 - 2374
  • [39] Rational Design of Peptide-Based Tumor Vaccines
    Wilson S. Meng
    Lisa H. Butterfield
    Pharmaceutical Research, 2002, 19 : 926 - 932
  • [40] Harnessing the immunogenicity of peptide-based glycoconjugate vaccines
    Stefanetti, Giuseppe
    Okan, Nihal
    Kasper, Dennis L.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
12345